Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Aisen P (1994) The transferrin receptor and the release of iron from transferrin. Adv Exp Med Biol 365:31–40
Aksentijevich L, Lunaridi-Iskandar Y, Gallo C, Gottesman M, Thrierry AR (1996) In vitro and liposome-mediated gene trasfer leads to human MDR1 expression in mouse bone marrow progenitor cell. Hum. Gene Ther 7:1111–1122
Allen TM, Hansen C, Martin F, Redemann C, Young AY (1991) Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta 1066:29–36
Aragnol D, Leserman LD (1986) Immune clearance of liposomes inhibited by an anti-Fc receptor antibody in vivo. Proc. Natl Acad Set USA 83:2699–2703
Blume G, Cevc G (1990) Liposomes for sustained drug release in vivo. Biochim Biophys Acta 1029:91–97
Cummings J, Smyth JF (1993) Cytotoxic drug delivery. In: “Topics in phannacy, Vol. III.” Florence AT Salole EG (Eds) Butterworth-Heinemann, Oxford, p 27–53
Derksen JTP, Morselt HWM, Scherphof GL (1988) Uptake and processing of immunoglobulin-coated liposomes by subpopulation of rat liver macrophages. Biochim Biophys Acta 971:127–136
Dvorak HF, Nagy JA, Dvorak JT (1988) Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol 133:95–109
Ehrlich PA (1956) General review of the recent work in immunity. In “Immunology and cancer research.” Himmelweit F (Ed.). Pergamon Press, London.
Enoch HG, Strittmatter P (1979) Formation and properties of 1000-Å-diameter, singlebilayer phospholipid vesicles. Proc Natl Acad Sci USA 76:145–149
Feero WG, Li S, Rosenblatt JD, Sirianni N, Morgan JE, Partridge TA, Huang L, Hoffman EP (1997) Selection and use of lighands for receptor-mediated gene delivery to myogenic cells. Gene Ther 4:664–674
Felgner JH, Kumar R, Sridhar CN, Wheeler CJ, Tsai YJ, Border R, Ramsey P, Martin M, Felgner PL (1994) Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem 269:2550–2561
Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, Danielsen M (1987) Lipofection: a highly efficient lipid-mediated DNA trancefection procedure. Proc. Natl Acid Sci USA 84:7413–7417
Fenske D, MacLachlan I, Cullis PR (2002) Stabilized plasmid-lipid particles: A systemic gene therapy vector method in engymology 346 ed by M I Phillips 36–71
Gabizon A (1992) Cancer Res 52:891–896
Gabizon A, Papahadjopoulos D (1988) Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci USA 85:6949–6953
Gregoriadis G (1998) Genetic Vaccines: Strategies for Optimisation. Pharm Res 15:661–670
Gupta PK (1990) Drug targeting in cancer chemotherapy: a clinical perspective. J Pharm Sci 79:949–962
Harashima H, Shinohara Y, Kiwada H (2001) Intracellular control of gene trafficking using liposomes as drug carriers. Eur J Pharm Sci 13:85–89
Harata M, Soda Y, Tani K, Takizawa T, Maruyama K, Tojo A, Asano S (2004) CD19-targeting liposomes containing imatinib efficiently kill Philadelphia chromosome-positive acute Lymphoblastic leukemia cells. Blood 104:1442–1449
Huang SK, Lee KD, Hong K, Friend DS, Papahadjopoulos D (1992) Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice. Cancer Res 52:5135–5143
Huebers HA, Finch CA (1987) The physiology of transferrin and transferrin receptors. Physiol Rev 67:520–582
Ishida O, Maruyama K, Sasaki K, Iwatsuru M (1999) Size-dependent extravasation ant interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice. Int J Pharm 190:49–56
Ishida O, Maruyama K, Tanahashi H, Iwatsuru M, Sasaki K, Eriguchi M, Yanagie H (2001) Liposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo. Pharm Res 18(7):1042–1048
Ishikawa E, Imagawa H, Hashida S, Yashitake S, Hamaguchi Y, Ueno T (1983) Enzyme labeling antibodies and their fragments for enzyme immunoassay and immunohistochemical staining. J Immunoassay 4:209–327
Jain RK, Gerlowski LE (1986) Extravascular transport in normal and tumor tissue. Crit Rev Oncol Hematol 5:115–170
Kakudo T, Chaki S, Futaki S, Nakase I, Akaji K, Kawakami T, Maruyama K, Kamiya H, Harashima H (2004) Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: An artificial viral-like delivery system. Biochemistry 43:5618–5628
Kamiya H, Tsuchiya H, Yamazaki J, Harashima H (2001) Intracellular trafficking and transgene expression of viral and non-viral gene vectors. Adv Drug Deliv Rev 52:153–164
Kennel SJ, Lankfold T, Hughes B, Hotchkiss JA (1988) Quantitation of a murine lung endothelial cell protein, P112, with a double monoclonal antibody assay. Laboratory Investigation 59:692–701
Klibanov A, Huang L (1992) Long-circulating liposomes: Development and perspectives. J Liposome Res 2:321–334
Klibanov A, Maruyama K, Beckerleg A, Torchilin VP, Huang L (1991) Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim Biophys Acta 1062:142–148
Klibanov A, Maruyama K, Torchilin VP, Huang L (1990) Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 268:235–237
Lasic D, Martin F (1995) Stealth Liposomes. CRC Press, Inc Boca Raton
Li S, Rizzo MA, Bhattacharya S, Huang L (1998) Characterization of cationic lipidprotamine-DNA (LPD) complexes for intravenous gene delivery. Gene Therapy 5:930–937
Li S, Tseng WC, Stolz DB, Wu SP, Watkins SC, Huang L (1999) Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection. Gene Therapy 6:858–594
Liu F, Qi H, Huang L, Liu D (1997) Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration. Gene Ther 4:517–523
Maeda H (1992) The tumor blood vessel as an ideal target for macromolecular anticancer agents. J Control Release 19:315–324
Maeda H, Seymour LW, Miyamoto Y (1992) Conjugation of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. Bioconjug Chem 3:351–362
Maruyama K, Holmberg E, Kennel S, Klibanov A, Torchilin VP, Huang L (1990) Characterization of in vivo immunoliposomes targeting to pulmonary endothelium. J Pharm Sci 79:978–984
Maruyama K, Kennel SJ, Huang L (1990) Lipid composition is important for highly efficient target binding and retention of immunoliposomes. Proc Natl Acad Sci USA 87:5744–5748
Maruyama K, Takahashi N, Tagawa T, Nagaike K, Iwatsuru M (1997a) Immunoliposomes bearing polyethyleneglycol-coupled Fab′ fragment show prolonged circulation time and high extravasation into target solid tumors in vivo. 413:177–180
Maruyama K, Takizawa T, Takahashi N, Tagawa T, Nagaike K, Iwatsuru M (1997b) Advanced Drug Delivery Reviews 24:235–242
Maruyama K, Takizawa T, Yuda T, Kennel SJ, Huang L, Iwatsuru M (1995) Targetability of novel immunoliposomes modified with amphipathic polyethyleneglycols conjugated at their distal terminals to monoclonal antibodies. Biochim Biophys Acta 1234:74–80
Maruyama K, Yanagie H, Ishida O, Kasaoka S, Takizawa T, Utoguchi N, Shinohara A, Chiba M, Kobayashi H, Iwatsuru M, Eriguchi M (2004) Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT). J Controlled Release 98(2):195–207
Maruyama K, Yuda T, Okamoto S, Kojima S, Suginaka A, Iwatsuru M (1992) Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoylphosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). Biochim Biophys Acta 1128:44–49
Miller AD (1998) Cationic liposomes for gene therapy. Angew Chem Int Ed 37:1768–1785
Mori A, Klibanov A, Torchilin VP, Huang L (1991) Influence of the steric barrier activity of amphipathic poly(ethylene glycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo. FEBS Let 284:263–266
Nabel GJ, Nabel EG Yang ZY, Fox BA, Plautz GE, Gao X, Huang L, Shu S, Gordon D (1993) Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity. Proc. Natl Acad Sci USA 90:11307–11311
Nir S, Nieva JL (2000) Interactions of peptides with liposomes: pore formation and fusion. Prog Lipid Res 39:181–206
Papahadjopoulos D, Allen TM, Gabizon A, Mayhew E, Matthay K, Huang SK, Lee KD, Woodle MC, Lasic DD, Redemann C, Martin FJ (1991) Proc Natl Acad Sci USA 88: 11460–11464
Peeters PAM, Storm G, Crommelin DJA (1987) Liposomes in vivo: state of the art. Advanced Drug Delivery Review 1:249–266
Perrie Y, Gregoriadis G (2000) Liposome-Entrapped Plasmid DNA: Characterisation Studies. Biochim Biophys Acta 1475:125–132
Poste G, Kirsh R (1983) Site-specific (targeted) drug delivery in cancer therapy. Biotechnology 1:869–878
Rowlinson-Busza G, Epenetos AA (1992) Targeted delivery of biologic and other antineoplastic agents. Curr Opin Oncol 4:1142–1148
Sorgi FL, Bhattacharya S, Huang L (1997) Protamine sulfate enhances lipid mediated gene transfer. Gene Therapy 4:961–968
Subbarao NK, Parente RA, Szoka FC, Jr Nadasdi L, Pongracz K (1987) pH-dependent bilayer destabilization by an amphipathic peptide. Biochemistry 26:2964–2972
Takizawa T, Maruyama K, Iwatsuru M, Sasaki K (1998) Drug Delivery System 13:407–414
Templeton NS, Lasic DD, Frederik PM, Strey HH, Roberts DD, Pavlakis GN (1997) Improved DNA: liposome complexed systemic delivery and gene expressin. Nature Biotechnology 15:642–652
Unezaki S, Maruyama K, Hosoda J, Nagae I, Koyanagi Y, Nakata M, Ishida O, Iwatsuru M, Tsuchiya S (1996) Direct measurement of the extravasation of polyethyleneglycol-coated liposomes into solid tumor tissue by in vivo fluorescence microscopy. Int J Pharm 144:11–17
Unezaki S, Maruyama K, Ishida O, Suginaka A, Hosoda J, Iwatsuru M (1995) Enhanced tumor targeting and improved antitumor activity of doxorubicin by long-circulating liposomes containing amphipathic poly(ethylene glycol). Int J Pharm 126:41–48
Unezaki S, Maruyama K, Takahashi N, Koyama M, Yuda T, Suginaka A, Iwatsuru M (1994) Enhanced delivery and antitumor activity of doxorubicin using long-circulating thermosensitive liposomes containing amphipathic polyethyleneglycol in combination with local hyperthermia. Pharm Res 11:1180–1185
Uyama I, Kumai K, Yasuda T, Tagawa T, Ishibiki K, Kitajima M, Tadakuma T (1994) Improvement of therapeutic effect by using Fab′ fragment in the treatment of carcinoembryonic antigen-positive human solid tumors with adriamycin-entrapped immunoliposomes. Jpn J Cancer Res 85:434–440
Wagner E, Curiel D, Cotton M (1994) Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor-mediated endocytosis. Advanced Drug Delivery Reviews 14:113–135
Wheeler JJ, Palmer L, Ossanlou M, MacLachlan I, Graham RW, Zhang YP, Hope MJ, Scherrer P, Cullis PR (1999) Gene Ther 6:271
Wright S, Huang L (1989) Antibody-directed liposomes as drug delivery vehicles. Advanced Drug Delivery Reviews 3:343–389
Xu L, Pirollo KF, Rait A, Murray A, Chang EH (1999) Systemic p53 Gene Therapy in Combination Rediation Result in Human Tumor Regression. Tumor-Targeting 4:92–114
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Tokyo
About this chapter
Cite this chapter
Maruyama, K. (2005). Liposomes. In: Taira, K., Kataoka, K., Niidome, T. (eds) Non-viral Gene Therapy. Springer, Tokyo. https://doi.org/10.1007/4-431-27879-6_3
Download citation
DOI: https://doi.org/10.1007/4-431-27879-6_3
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-25122-4
Online ISBN: 978-4-431-27879-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)